September 26 2019, 4:00pm - 5:00pm ET
Join Doctors Without Borders for an exciting webcast discussion about how medical research is used to improve care for those most in need.
Medical research has profound consequences on the lives and health of people around the world. Which diseases get funding and attention, what drugs and diagnostic tests are developed, and who benefits?
Doctors Without Borders/Médecins Sans Frontières (MSF) conducts research rooted in our medical projects because we see how the knowledge gap hurts neglected communities. There simply aren’t enough researchers asking relevant questions about the medical needs of the people we treat, including victims of war, malnourished children, those affected by tropical diseases, and people living in areas prone to epidemics of diseases like cholera or Ebola.
We also have unique expertise. Because our teams provide medical care to some of the most at-risk populations in more than 70 countries, we are able to provide high-quality answers to urgent research questions. We also work to ensure that our findings are used to benefit the patients and the communities involved. Over the years, MSF field research has improved the delivery of lifesaving HIV treatment, changed global malaria treatment protocols, and helped prove the efficacy of Ebola treatments, among other achievements.
Join us for a discussion with a panel of MSF experts about how medical research helps improve the quality of the care we provide and influences global public health policy. The panelists will discuss key projects as well as the principles of medical ethics. Participants include Dr. Emmanuel Baron, general director of Epicentre, MSF’s epidemiological research division; Dr. Yap Boum, Epicentre representative for Africa; Dr. Matthew Coldiron, medical epidemiologist for Epicentre/MSF; and Dr. Helena Huerga, medical epidemiologist for Epicentre/MSF. The discussion will be moderated by Brienne Prusak, medical and global health press officer for MSF-USA.
At the time of the event, tune in to our webcast here. Audience Q&A will be provided via the chat.